Aurentz Vincent has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a disposition of 255299 shares of Inhibikase Therapeutics, Inc. ($IKT) on February 21, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 21, 2026 | Inhibikase Therapeutics, Inc. | $IKT | Aurentz Vincent | Not found | D | Common Stock | 255299 | $0.00 | 510,596.0000 | 90,050,973 | 33.33% | 0.28% |
| June 30, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Aurentz Vincent | Not found | A | Stock Option (Right to Buy) | 108176 | $0.00 | 108,176.0000 | 23,712,220 | 9999.99% | 0.46% |
| Feb. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Aurentz Vincent | Not found | A | Stock Option (Right to Buy) | 134427 | $0.00 | 134,427.0000 | 23,712,220 | 9999.99% | 0.57% |
| Feb. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Aurentz Vincent | Not found | A | Stock Option (Right to Buy) | 134427 | $0.00 | 134,427.0000 | 23,712,220 | 9999.99% | 0.57% |